APO RESEARCH · REPORT
mRNA Raw Enzyme
mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.
Product & engineering
Understand the product.
mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.
Selected research
Industry Research
mRNA Raw Enzyme Industry Research Report 2026
Market perspective
mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.
The global mRNA Raw Enzyme market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the mRNA Raw Enzyme market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the mRNA Raw Enzyme market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the mRNA Raw Enzyme market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of mRNA Raw Enzyme include Thermo Fisher, NEB, Merck, Aldevron, Roche CustomBiotech, Takara Bio Inc., Qiagen N.V., Promega and Novoprotein, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Read the full market overview
Report Scope
This report quantifies the global mRNA Raw Enzyme market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to mRNA Raw Enzyme.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
mRNA Raw Enzyme Market by Company
Thermo Fisher
NEB
Merck
Aldevron
Roche CustomBiotech
Takara Bio Inc.
Qiagen N.V.
Promega
Novoprotein
Alphazyme
LGC Biosearch Technologies
Jena Bioscience
Yeasen Biotechnology
Hongene Biotech
Enzo Biochem
Spindle (Applied DNA Sciences)
Vazyme
mRNA Raw Enzyme Segment by Type
Restriction Enzyme
RNA Polymerase
Capping Enzyme
Inorganic Pyrophosphatase
RNase Inhibitor
2'-O-Methyltransferase
Poly(A) Polymerase
DNase I
mRNA Raw Enzyme Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
mRNA Raw Enzyme Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Raw Enzyme market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of mRNA Raw Enzyme and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Raw Enzyme.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of mRNA Raw Enzyme companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Restriction Enzyme
- RNA Polymerase
- Capping Enzyme
- Inorganic Pyrophosphatase
- RNase Inhibitor
- 2'-O-Methyltransferase
- Poly(A) Polymerase
- DNase I
Applications
- Biopharmaceutical Companies
- Academic and Research Institutes
Companies covered
- Thermo Fisher
- NEB
- Merck
- Aldevron
- Roche CustomBiotech
- Takara Bio Inc.
- Qiagen N.V.
- Promega
- Novoprotein
- Alphazyme
- LGC Biosearch Technologies
- Jena Bioscience
- Yeasen Biotechnology
- Hongene Biotech
- Enzo Biochem
- Spindle (Applied DNA Sciences)
- Vazyme
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 mRNA Raw Enzyme by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Restriction Enzyme
- 2.2.3 RNA Polymerase
- 2.2.4 Capping Enzyme
- 2.2.5 Inorganic Pyrophosphatase
- 2.2.6 RNase Inhibitor
- 2.2.7 2'-O-Methyltransferase
- 2.2.8 Poly(A) Polymerase
- 2.2.9 DNase I
- 2.3 mRNA Raw Enzyme by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical Companies
- 2.3.3 Academic and Research Institutes
- 2.4 Assumptions and Limitations
3 mRNA Raw Enzyme Breakdown Data by Type
- 3.1 Global mRNA Raw Enzyme Historic Market Size by Type (2021-2026)
- 3.2 Global mRNA Raw Enzyme Forecasted Market Size by Type (2027-2032)
4 mRNA Raw Enzyme Breakdown Data by Application
- 4.1 Global mRNA Raw Enzyme Historic Market Size by Application (2021-2026)
- 4.2 Global mRNA Raw Enzyme Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global mRNA Raw Enzyme Market Perspective (2021-2032)
- 5.2 Global mRNA Raw Enzyme Growth Trends by Region
- 5.2.1 Global mRNA Raw Enzyme Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 mRNA Raw Enzyme Historic Market Size by Region (2021-2026)
- 5.2.3 mRNA Raw Enzyme Forecasted Market Size by Region (2027-2032)
- 5.3 mRNA Raw Enzyme Market Dynamics
- 5.3.1 mRNA Raw Enzyme Industry Trends
- 5.3.2 mRNA Raw Enzyme Market Drivers
- 5.3.3 mRNA Raw Enzyme Market Challenges
- 5.3.4 mRNA Raw Enzyme Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top mRNA Raw Enzyme Players by Revenue
- 6.1.1 Global Top mRNA Raw Enzyme Players by Revenue (2021-2026)
- 6.1.2 Global mRNA Raw Enzyme Revenue Market Share by Players (2021-2026)
- 6.2 Global mRNA Raw Enzyme Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of mRNA Raw Enzyme Head Office and Area Served
- 6.4 Global mRNA Raw Enzyme Players, Product Type & Application
- 6.5 Global mRNA Raw Enzyme Manufacturers Established Date
- 6.6 Global mRNA Raw Enzyme Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America mRNA Raw Enzyme Market Size (2021-2032)
- 7.2 North America mRNA Raw Enzyme Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America mRNA Raw Enzyme Market Size by Country (2021-2026)
- 7.4 North America mRNA Raw Enzyme Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe mRNA Raw Enzyme Market Size (2021-2032)
- 8.2 Europe mRNA Raw Enzyme Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe mRNA Raw Enzyme Market Size by Country (2021-2026)
- 8.4 Europe mRNA Raw Enzyme Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific mRNA Raw Enzyme Market Size (2021-2032)
- 9.2 Asia-Pacific mRNA Raw Enzyme Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific mRNA Raw Enzyme Market Size by Country (2021-2026)
- 9.4 Asia-Pacific mRNA Raw Enzyme Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America mRNA Raw Enzyme Market Size (2021-2032)
- 10.2 South America mRNA Raw Enzyme Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America mRNA Raw Enzyme Market Size by Country (2021-2026)
- 10.4 South America mRNA Raw Enzyme Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa mRNA Raw Enzyme Market Size (2021-2032)
- 11.2 Middle East & Africa mRNA Raw Enzyme Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa mRNA Raw Enzyme Market Size by Country (2021-2026)
- 11.4 Middle East & Africa mRNA Raw Enzyme Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher
- 12.1.1 Thermo Fisher Company Information
- 12.1.2 Thermo Fisher Business Overview
- 12.1.3 Thermo Fisher Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.1.4 Thermo Fisher mRNA Raw Enzyme Product Portfolio
- 12.1.5 Thermo Fisher Recent Developments
- 12.2 NEB
- 12.2.1 NEB Company Information
- 12.2.2 NEB Business Overview
- 12.2.3 NEB Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.2.4 NEB mRNA Raw Enzyme Product Portfolio
- 12.2.5 NEB Recent Developments
- 12.3 Merck
- 12.3.1 Merck Company Information
- 12.3.2 Merck Business Overview
- 12.3.3 Merck Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.3.4 Merck mRNA Raw Enzyme Product Portfolio
- 12.3.5 Merck Recent Developments
- 12.4 Aldevron
- 12.4.1 Aldevron Company Information
- 12.4.2 Aldevron Business Overview
- 12.4.3 Aldevron Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.4.4 Aldevron mRNA Raw Enzyme Product Portfolio
- 12.4.5 Aldevron Recent Developments
- 12.5 Roche CustomBiotech
- 12.5.1 Roche CustomBiotech Company Information
- 12.5.2 Roche CustomBiotech Business Overview
- 12.5.3 Roche CustomBiotech Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.5.4 Roche CustomBiotech mRNA Raw Enzyme Product Portfolio
- 12.5.5 Roche CustomBiotech Recent Developments
- 12.6 Takara Bio Inc.
- 12.6.1 Takara Bio Inc. Company Information
- 12.6.2 Takara Bio Inc. Business Overview
- 12.6.3 Takara Bio Inc. Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.6.4 Takara Bio Inc. mRNA Raw Enzyme Product Portfolio
- 12.6.5 Takara Bio Inc. Recent Developments
- 12.7 Qiagen N.V.
- 12.7.1 Qiagen N.V. Company Information
- 12.7.2 Qiagen N.V. Business Overview
- 12.7.3 Qiagen N.V. Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.7.4 Qiagen N.V. mRNA Raw Enzyme Product Portfolio
- 12.7.5 Qiagen N.V. Recent Developments
- 12.8 Promega
- 12.8.1 Promega Company Information
- 12.8.2 Promega Business Overview
- 12.8.3 Promega Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.8.4 Promega mRNA Raw Enzyme Product Portfolio
- 12.8.5 Promega Recent Developments
- 12.9 Novoprotein
- 12.9.1 Novoprotein Company Information
- 12.9.2 Novoprotein Business Overview
- 12.9.3 Novoprotein Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.9.4 Novoprotein mRNA Raw Enzyme Product Portfolio
- 12.9.5 Novoprotein Recent Developments
- 12.10 Alphazyme
- 12.10.1 Alphazyme Company Information
- 12.10.2 Alphazyme Business Overview
- 12.10.3 Alphazyme Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.10.4 Alphazyme mRNA Raw Enzyme Product Portfolio
- 12.10.5 Alphazyme Recent Developments
- 12.11 LGC Biosearch Technologies
- 12.11.1 LGC Biosearch Technologies Company Information
- 12.11.2 LGC Biosearch Technologies Business Overview
- 12.11.3 LGC Biosearch Technologies Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.11.4 LGC Biosearch Technologies mRNA Raw Enzyme Product Portfolio
- 12.11.5 LGC Biosearch Technologies Recent Developments
- 12.12 Jena Bioscience
- 12.12.1 Jena Bioscience Company Information
- 12.12.2 Jena Bioscience Business Overview
- 12.12.3 Jena Bioscience Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.12.4 Jena Bioscience mRNA Raw Enzyme Product Portfolio
- 12.12.5 Jena Bioscience Recent Developments
- 12.13 Yeasen Biotechnology
- 12.13.1 Yeasen Biotechnology Company Information
- 12.13.2 Yeasen Biotechnology Business Overview
- 12.13.3 Yeasen Biotechnology Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.13.4 Yeasen Biotechnology mRNA Raw Enzyme Product Portfolio
- 12.13.5 Yeasen Biotechnology Recent Developments
- 12.14 Hongene Biotech
- 12.14.1 Hongene Biotech Company Information
- 12.14.2 Hongene Biotech Business Overview
- 12.14.3 Hongene Biotech Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.14.4 Hongene Biotech mRNA Raw Enzyme Product Portfolio
- 12.14.5 Hongene Biotech Recent Developments
- 12.15 Enzo Biochem
- 12.15.1 Enzo Biochem Company Information
- 12.15.2 Enzo Biochem Business Overview
- 12.15.3 Enzo Biochem Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.15.4 Enzo Biochem mRNA Raw Enzyme Product Portfolio
- 12.15.5 Enzo Biochem Recent Developments
- 12.16 Spindle (Applied DNA Sciences)
- 12.16.1 Spindle (Applied DNA Sciences) Company Information
- 12.16.2 Spindle (Applied DNA Sciences) Business Overview
- 12.16.3 Spindle (Applied DNA Sciences) Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.16.4 Spindle (Applied DNA Sciences) mRNA Raw Enzyme Product Portfolio
- 12.16.5 Spindle (Applied DNA Sciences) Recent Developments
- 12.17 Vazyme
- 12.17.1 Vazyme Company Information
- 12.17.2 Vazyme Business Overview
- 12.17.3 Vazyme Revenue in mRNA Raw Enzyme Business (2021-2026)
- 12.17.4 Vazyme mRNA Raw Enzyme Product Portfolio
- 12.17.5 Vazyme Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst